Collateral for a security interest recorded Jan 24, 2025 (Trinity Capital Inc.).
Term ends Feb 17, 2044 · High confidence
20-year base term ends Sep 29, 2041
Held by Cagent Vascular, Inc.
Filed Sep 29, 2021 as application 17/489,375 · Granted Jun 2, 2026
Base term plus 871 days of patent term adjustment (USPTO delay)
Today
2021
2044
Clock starts
Sep 29, 2021
Sep 29, 2021
Term ends
Feb 17, 2044
Feb 17, 2044
Granted
Jun 2, 2026
Jun 2, 2026
base term
patent term adjustment
Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
871
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
None
Terminal disclaimer
No disclaimer on this record.
0 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
4
Family applications on record here
Applications sharing this one's continuity chain, as the file histories and patent records this site holds name them. The family may have others.
This patent's term runs 871 days past its 20-year base term on prosecution delay. 0 of 3 maintenance fees are paid so far. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Sep 29, 2021, when this application, 17/489,375, was filed | Sep 29, 2041 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | +871 days, USPTO patent term adjustment record | Feb 17, 2044 | High confidence |
| Terminal disclaimer cap | None on record | no cap applied | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 0 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Feb 17, 2044 | High confidence |
This family
| US 12,642,946 | this patent Feb 2044 | Feb 2044 |
| Application 19/669,391 | Pending not computed | not computed |
| Application 19/669,420 | Pending not computed | not computed |
| Application 19/669,469 | Pending not computed | not computed |
Every application listed has its file history here. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Jan 18, 2022 Reel 58684, frame 743 | Giasolli, Robert M.; Johansson, Peter | Cagent Vascular, Inc. | Assignment of Assignor's Interest |
| Jan 24, 2025 Reel 70005, frame 936 | Cagent Vascular, Inc. | Trinity Capital Inc., as Collateral Agent | Security Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
What's changing
Feb 2044
Term ends Feb 17, 2044. Maintenance fees still fall due before then
Note
The 871 days of patent term adjustment (USPTO delay) are read from the USPTO record, not recalculated by us
Citations
We have no citation count for this patent yet. That is not the same as never having been cited.
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.